AG2R La Mondiale Gestion d'Actifs’s Regeneron Pharmaceuticals REGN Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.96M	Buy	4,755 +418	+10%	+$285K	0.11%	175
2026 Q1	$3.35M	Sell	4,337 -7	-0.2%	-$5.36K	0.15%	131
2025 Q4	$3.35M	Sell	4,344 -109	-2%	-$74K	0.15%	116
2025 Q3	$2.34M	Hold	4,453	–	–	0.12%	164
2025 Q2	$2.34M	Buy	4,453 +348	+8%	+$194K	0.12%	164
2025 Q1	$2.01M	Buy	+4,105	New	+$2.82M	0.11%	173

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's REGN Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Regeneron Pharmaceuticals (REGN) stake by 9.6% in Q2 2026, buying an estimated $285K and bringing the position to 4,755 shares worth $2.96M. The position accounts for 0.11% of the portfolio, ranked #175.

AG2R La Mondiale Gestion d'Actifs first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.35M in Q4 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 4,755 shares of Regeneron Pharmaceuticals worth $2.96M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 418 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $285K.
Regeneron Pharmaceuticals made up 0.11% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #175 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
AG2R La Mondiale Gestion d'Actifs's Regeneron Pharmaceuticals position peaked at $3.35M in Q4 2025.
334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.